Affymax Inc Com (NASDAQOTH:AFFY)

CAPS Rating: 1 out of 5

The Company is a biopharmaceutical company developing novel peptide-based drug candidates to improve the treatment of serious and often life-threatening conditions.

Recs

1
Player Avatar TMFBiologyFool (95.87) Submitted: 12/5/2011 2:07:27 PM : Underperform Start Price: $6.18 AFFY Score: +112.25

Bet against the FDA advisory panel.

Featured Broker Partners


Advertisement